GCTKGlucoTrack, Inc.

Nasdaq glucotrack.com


$ 0.57 $ 0.00 (-0.5 %)    

Thursday, 09-May-2024 15:56:26 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 0.5602
$ 0.59
$ 0.00 x 0
$ 0.66 x 100
$ 0.57 - $ 0.59
$ 0.13 - $ 0.99
70,454
na
11.63M
$ 2.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-21-2021 03-31-2021 10-Q
13 04-13-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-19-2020 03-31-2020 10-Q
17 04-14-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-Q
21 04-15-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-30-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-16-2015 09-30-2015 10-Q
35 08-14-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 03-31-2015 12-31-2014 10-K
38 11-14-2014 09-30-2014 10-Q
39 08-19-2014 06-30-2014 10-Q
40 05-13-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 glucotrack-announces-expansion-of-its-continuous-glucose-monitoring-technology-to-epidural-glucose-monitoring

Expansion offers the potential for continuous, discreet and simplified epidural glucose monitoring solutions for patients with ...

 glucotrack-announces-increased-sensor-longevity-for-its-implantable-continuous-blood-glucose-monitor

Computational modeling with The Technology Partnership shows sensor longevity beyond 3 years; 1 year longer than previously ann...

 glucotrack-announces-the-appointment-of-luis-malav-to-chair-of-the-board-of-directors-effective-immediately

Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company"), a medical device company focused on the design,...

 glucotrack-announces-early-accuracy-data-for-its-implantable-continuous-glucose-monitor-announces-the-successful-completion-of-their-first-preclinical-study-of-the-implantable-cbgm

GlucoTrack, Inc. (NASDAQ:GCTK) ("GlucoTrack" or the "Company"), a medical device company focused on the design,...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION